Immunome, Inc. (IMNM)
NASDAQ: IMNM · IEX Real-Time Price · USD
13.37
+0.05 (0.41%)
Jul 22, 2024, 10:15 AM EDT - Market open
Immunome Employees
Immunome had 55 employees as of December 31, 2023. The number of employees increased by 18 or 48.65% compared to the previous year.
Employees
55
Change (1Y)
18
Growth (1Y)
48.65%
Revenue / Employee
$230,600
Profits / Employee
-$4,218,691
Market Cap
803.58M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 55 | 18 | 48.65% |
| Dec 31, 2022 | 37 | -2 | -5.13% |
| Dec 31, 2021 | 39 | 16 | 69.57% |
| Dec 31, 2020 | 23 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Atrion | 712 |
| Cytek Biosciences | 676 |
| Clover Health Investments | 552 |
| Standard BioTools | 539 |
| Aurinia Pharmaceuticals | 300 |
| OrthoPediatrics | 247 |
| Simulations Plus | 197 |
| Olema Pharmaceuticals | 74 |
IMNM News
- 25 days ago - Immunome Appoints Phil Tsai as Chief Technical Officer - Business Wire
- 2 months ago - Immunome Announces Completion of Purchase of Assets from Atreca - Business Wire
- 2 months ago - Immunome Announces Promotion of Max Rosett to Chief Financial Officer - Business Wire
- 2 months ago - Immunome Reports First Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 2 months ago - Immunome to Present at 2024 Bank of America Healthcare Conference - Business Wire
- 2 months ago - Immunome Appoints Kinney Horn as Chief Business Officer - Business Wire
- 3 months ago - Immunome Appoints Sandra M. Swain to Board of Directors - Business Wire
- 3 months ago - Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting - Business Wire